BlueCrest Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-12,600	Closed	-$224K	–	848
2018 Q3	$224K	Buy	+12,600	New	+$224K	0.01%	1194